- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04225845
The Economic Consequences of Loneliness Among the Elderly
March 27, 2023 updated by: Esther Duflo, National Bureau of Economic Research, Inc.
Elderly individuals across the world are increasingly living alone.
However, little is known about the effects of loneliness on economic and health outcomes.
The elderly living alone (i.e., in a household of size 1) will be randomized into one of two cross-randomized intervention arms or a control condition to improve older individuals' mental wellbeing as well as ability to cover basic needs, particularly in times of COVID (including health).
The first intervention will focus on improving the elderly's outlook on life and relationships through problem-solving therapy (PST) delivered over the phone.
The second will deliver to them a one-time cash transfer of Rs.1000, equivalent to the emergency help amount distributed to ration card holder by the government of Tamil Nadu.
Each intervention will be offered on its own in each of two treatment arms, and in combination in a third.
A control group will receive no intervention.
Investigators will track outcomes of the elderly at 3 weeks and 3 months after the intervention.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India
- JPAL SA at IFMR
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 55 years of age
- Individuals living alone
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Control group.
|
|
Experimental: Phone therapy
Weekly phone calls by lay trained personnel to deliver problem solving therapy.
|
Weekly phone calls by lay trained personnel to deliver problem solving therapy.
|
Experimental: Phone therapy plus cash transfer
Weekly phone calls by lay trained personnel to deliver problem solving therapy.
Combined with a one-time cash transfer of Rs.1000.
|
Weekly phone calls by lay trained personnel to deliver problem solving therapy.
One-time cash transfer of Rs.1000.
|
Experimental: Cash transfer
One-time cash transfer of Rs.1000.
|
One-time cash transfer of Rs.1000.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difficulty in performing daily activities/Functional impairment score
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be asked the level of difficulty they have in doing each of the following tasks: standing for 30 minutes, walking a long distance (1km), concentrating for 10 minutes, learning a new task like getting to a new place, washing whole body, getting dressed, taking care of household activities, doing day-to-day work, dealing with people they do not know, maintaining a friendship, being emotionally affected by health problems, and joining in community activities.
The scale is from 0-4, with 0 being no difficulty, 1 mild, 2 moderate, 3 severe, and 4 cannot do.
The scores will be summed to create a cumulative score on a 0-48 scale.
|
Assessed at 3 weeks after intervention
|
Difficulty in performing daily activities/Functional impairment score
Time Frame: Assessed at 3 months after intervention
|
Participants will be asked the level of difficulty they have in doing each of the following tasks: standing for 30 minutes, walking a long distance (1km), concentrating for 10 minutes, learning a new task like getting to a new place, washing whole body, getting dressed, taking care of household activities, doing day-to-day work, dealing with people they do not know, maintaining a friendship, being emotionally affected by health problems, and joining in community activities.
The scale is from 0-4, with 0 being no difficulty, 1 mild, 2 moderate, 3 severe, and 4 cannot do.
The scores will be summed to create a cumulative score on a 0-48 scale.
|
Assessed at 3 months after intervention
|
Mental health
Time Frame: Assessed at 3 weeks after intervention
|
The geriatric depression index short form is used.
Participants are asked yes/no questions: if they are satisfied with their lives, have dropped activities and interests, feel their life is empty, often get bored, in good spirits most of the time, afraid that something bad is going to happen to them, feel happy most of the time, often feel hopeless, prefer to stay at home, rather than going out and doing new things, have problems with memory, think it is wonderful to be alive, feel worthless, feel full of energy, feel lonely, feel their situation is hopeless, think that most people are better off than they are.
Responses will be summed over these questions.
|
Assessed at 3 weeks after intervention
|
Mental health
Time Frame: Assessed at 3 months after intervention
|
The geriatric depression index short form is used.
Participants are asked yes/no questions: if they are satisfied with their lives, have dropped activities and interests, feel their life is empty, often get bored, in good spirits most of the time, afraid that something bad is going to happen to them, feel happy most of the time, often feel hopeless, prefer to stay at home, rather than going out and doing new things, have problems with memory, think it is wonderful to be alive, feel worthless, feel full of energy, feel lonely, feel their situation is hopeless, think that most people are better off than they are.
Responses will be summed over these questions.
|
Assessed at 3 months after intervention
|
Food security
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be asked to report whether in the past week they had to skip or cut the size of meals in the past week.
|
Assessed at 3 weeks after intervention
|
Food security
Time Frame: Assessed at 3 months after intervention
|
Participants will be asked to report whether in the past week they had to skip or cut the size of meals in the past week.
|
Assessed at 3 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival of elderly person
Time Frame: Assessed at 3 months after intervention
|
Whether still living at time of follow-up survey (0/1 variable)
|
Assessed at 3 months after intervention
|
Seeking or receiving COVID vaccine
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be asked if they received the COVID vaccine or sought it (went to the health center but there was no availability).
|
Assessed at 3 weeks after intervention
|
Seeking or receiving COVID vaccine
Time Frame: Assessed at 3 months after intervention
|
Participants will be asked if they received the COVID vaccine or sought it (went to the health center but there was no availability).
|
Assessed at 3 months after intervention
|
Loneliness
Time Frame: Assessed at 3 weeks after intervention
|
Measured using the short-form University of California, Los Angeles (UCLA) Loneliness Scale (aka ULS-4).
This is a 4-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation.
The questions are: no one really knows me well, people are around me but not with me, I feel in tune with the people around me, I can find companionship when I want it.
Subjects rate each item as either O ("I often feel this way"), S ("I sometimes feel this way"), R ("I rarely feel this way"), N ("I never feel this way").
Responses are summed over the four questions and rescaled to a 0-1 scale.
|
Assessed at 3 weeks after intervention
|
Loneliness
Time Frame: Assessed at 3 months after intervention
|
Measured using the short-form University of California, Los Angeles (UCLA) Loneliness Scale (aka ULS-4).
This is a 4-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation.
The questions are: no one really knows me well, people are around me but not with me, I feel in tune with the people around me, I can find companionship when I want it.
Subjects rate each item as either O ("I often feel this way"), S ("I sometimes feel this way"), R ("I rarely feel this way"), N ("I never feel this way").
Responses are summed over the four questions and rescaled to a 0-1 scale.
|
Assessed at 3 months after intervention
|
Healthcare utilization
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be asked if they fell ill in the last week, and, if yes, whether they used a medical provider or pharmacy to deal with the illness (0/1).
|
Assessed at 3 weeks after intervention
|
Healthcare utilization
Time Frame: Assessed at 3 months after intervention
|
Participants will be asked if they fell ill in the last week, and, if yes, whether they used a medical provider or pharmacy to deal with the illness (0/1).
|
Assessed at 3 months after intervention
|
Survival of elderly person
Time Frame: Assessed at 3 weeks after intervention
|
Whether still living at time of follow-up survey (0/1 variable)
|
Assessed at 3 weeks after intervention
|
Social integration: non-family
Time Frame: Assessed at 3 weeks after intervention
|
This is an indicator for whether the participant talked on the phone with anyone (with the exception of children and grandchildren) in the past week (0/1 scale).
|
Assessed at 3 weeks after intervention
|
Social integration: non-family
Time Frame: Assessed at 3 months after intervention
|
This is an indicator for whether the participant talked on the phone with anyone (with the exception of children and grandchildren) in the past week (0/1 scale).
|
Assessed at 3 months after intervention
|
Social integration: family
Time Frame: Assessed at 3 weeks after intervention
|
This is an indicator for whether the participant talked on the phone with children or grandchildren in the past week (0/1 scale).
|
Assessed at 3 weeks after intervention
|
Social integration: family
Time Frame: Assessed at 3 months after intervention
|
This is an indicator for whether the participant talked on the phone with children or grandchildren in the past week (0/1 scale).
|
Assessed at 3 months after intervention
|
Cognitive function
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be administered the mini mental state exam, scored on a 0-11 scale, rescaled to a 0-1 scale.
|
Assessed at 3 weeks after intervention
|
Cognitive function
Time Frame: Assessed at 3 months after intervention
|
Participants will be administered the mini mental state exam, scored on a 0-11 scale, rescaled to a 0-1 scale.
|
Assessed at 3 months after intervention
|
Consumption
Time Frame: Assessed at 3 weeks after intervention
|
Participants will be asked, for the last week, amount spent on different food items (rice, wheat, pulses, milk, spices, sugar, oil, meats, vegetables, fruits, packaged foods), medical expenses, fuel, clothing, footwear, toiletries, transportation, gifts, jewelry, and other expenses.
|
Assessed at 3 weeks after intervention
|
Consumption
Time Frame: Assessed at 3 months after intervention
|
Participants will be asked, for the last week, amount spent on different food items (rice, wheat, pulses, milk, spices, sugar, oil, meats, vegetables, fruits, packaged foods), medical expenses, fuel, clothing, footwear, toiletries, transportation, gifts, jewelry, and other expenses.
|
Assessed at 3 months after intervention
|
Health
Time Frame: Assessed at 3 weeks after intervention
|
This is a 16-point score comprised of indicators for whether the respondent faced health issues in the last week, according to the question, Did you face any health issues in the past week?, and then a follow-up in which the participant specified which health issues they faced.
For each of the following (unprompted) issues they faced, one point was added to their score: cold/runny nose/cough/sore throat, fever, diabetes/hypertension, excessive fatigue, dizziness, earache, chills/shivering, diarrhoea, vomiting, bloody stool/urine, body/joint pain, fall/injury, acute emergency, breathlessness, vision/hearing/skin problems, other.
Those who reported no health issues were given a score of zero.
|
Assessed at 3 weeks after intervention
|
Health
Time Frame: Assessed at 3 months after intervention
|
This is a 16-point score comprised of indicators for whether the respondent faced health issues in the last week, according to the question, Did you face any health issues in the past week?, and then a follow-up in which the participant specified which health issues they faced.
For each of the following (unprompted) issues they faced, one point was added to their score: cold/runny nose/cough/sore throat, fever, diabetes/hypertension, excessive fatigue, dizziness, earache, chills/shivering, diarrhoea, vomiting, bloody stool/urine, body/joint pain, fall/injury, acute emergency, breathlessness, vision/hearing/skin problems, other.
Those who reported no health issues were given a score of zero.
|
Assessed at 3 months after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Anticipated)
December 1, 2027
Study Completion (Anticipated)
December 1, 2027
Study Registration Dates
First Submitted
January 7, 2020
First Submitted That Met QC Criteria
January 8, 2020
First Posted (Actual)
January 13, 2020
Study Record Updates
Last Update Posted (Actual)
March 29, 2023
Last Update Submitted That Met QC Criteria
March 27, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 172020
- P01AG005842 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Loneliness
-
University of RochesterNational Institute on Aging (NIA)Recruiting
-
Vladimíra DostálováBarcelona Institute for Global HealthRecruiting
-
Taipei Medical UniversityCompleted
-
Linkoeping UniversityUniversity College, LondonCompleted
-
KTO Karatay UniversityCompleted
-
Florida State UniversityCompleted
-
Heartfulness InstituteCompletedLonelinessUnited States
-
Trustees of Dartmouth CollegeRecruiting
-
University of OregonNational Institute on Drug Abuse (NIDA); HopeLab FoundationCompleted
Clinical Trials on Phone therapy
-
Emory UniversityAlzheimer's AssociationCompleted
-
Kent State UniversityUtah State University; The University of AkronActive, not recruitingChronic Pain | Chiari MalformationUnited States
-
Duke UniversityRecruitingInsomnia | Posttraumatic Stress Disorder | Cardiovascular Risk FactorUnited States
-
Aliaa Rehan YoussefCompletedNeck Pain | Cervical PainEgypt
-
Michael C WilleyNot yet recruitingHip Pain Chronic | Hip Dysplasia | Hip Osteoarthritis | Hip Arthritis | Psychosocial ProblemUnited States
-
Walter Reed Army Medical CenterAffinity Networks, Inc.UnknownDiabetes MellitusUnited States
-
M.D. Anderson Cancer CenterCompletedProstate CancerUnited States, Canada
-
Centre Hospitalier Universitaire de BesanconHospices Civils de Lyon; University Hospital, Strasbourg, France; University... and other collaboratorsUnknownOut of Hospital Cardiac ArrestFrance
-
University of California, Los AngelesCompletedColorectal Cancer ScreeningUnited States
-
Baoshan Prefecture Center for Disease Control and...Prince of Songkla UniversityUnknownMedication AdherenceChina